Stockreport

VolitionRX Ltd (VNRX) Q3 2024 Earnings Report Preview: What to Look For [Yahoo! Finance]

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com
PDF The full year 2024's revenue is expected to be $2.13 million and the earnings are expected to be -$0.32 per share. More detailed estimate data can be found on the Foreca [Read more]